PLAUR and cancer: Although recent studies propose uPAR as a good candidate for antibody-targeted therapy in cancer [51,52,53,54,55], our results show that these treatments could, at the same time, induce cellular dormancy and render the tumor more resistant to chemotherapy (such as gemcitabine).